13 Jul Half-Year Trading Update
Sales growth of more than 900%, debt-free andsignificantly cashflow positiveDemand for COVID-19 test expected to continue into 2021 Paris, France and Camberley, UK – 13 July 2020 – Novacyt (EURONEXT GROWTH:...
30 Jun Publication of Annual Report
Paris, France and Camberley, UK – 30 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts...
18 Jun Launch of three innovative products to support COVID-19 testing
Paris, France and Camberley, UK – 18 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of three new products to...
03 Jun Règlement anticipé du prêt à terme et de la facilité d’émission d’obligations convertibles qui supprime la dette à long terme du Groupe
Paris, France et Camberley, Royaume-Uni – 3 juin 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce avoir réglé toutes ses dettes en...
03 Jun Early settlement of term loan and convertible bond facility removes long term debt
Paris, France and Camberley, UK – 3 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it will settle all outstanding debt obligations...
02 Jun Coronavirus update Sales and regulatory update
Paris, France and Camberley, UK – 2 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update on its polymerase chain reaction...
01 Jun Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 June 2020 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its monthly update in relation to ordinary shares traded...
14 May Final results for the year ended 31 December 2019 and outlook for 2020
Posted at 07:17h
in Board
Paris, France and Camberley, UK – 14 May 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its audited final results for the year...
29 Apr Coronavirus test update and notification of final results
Paris, France and Camberley, UK – 29 April 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update on its polymerase chain reaction...
27 Apr Contrat avec le Ministère de la Santé et des Affaires Sociales britannique pour la fourniture de tests COVID-19
Paris, France et Camberley, Royaume-Uni – 27 avril 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce avoir signé un contrat d’approvisionnement avec...